The Rise and Fall of a Controversial Fentanyl Drugmaker

This chapter explores the rise of a pharmaceutical company notorious for its fentanyl product, originally aimed at helping cancer patients. It contrasts the founder's intentions with the unethical practices that fueled the opioid epidemic, shedding light on the company's significant influence despite entering the market late.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.